Trading volume in the disinfectant maker's shares has been very active since February, which coincides with rising coronavirus fears.
I'm long GILD, but the fact is that the firm is not trying to make money off of Remdesivir at this point.
Quotient Limited and Redhill Biopharma could deliver for shareholders, while Novavax Inc. and Inovio Pharmaceuticals may not in the end.
Overall the charts of CNC are constructive but I would still want to buy strength.
Money movers are not buying protection for individual names, but they are starting to bet against the market en masse, while the Russell 2000 ran up 4% on Monday.
It is worth tracking these three names.
Overall the charts and indicators of UNH are constructive.
The economy and society suffer each day we stay closed, so let's look at the data on the Covid-19 crisis as well as on the economy to see what could be next.
The charts of the XLK and the XLV are impressive.
We have a new price target for GILD.